"experimentId","experimentTitle","genoType","cellType","parentCellLine","drugTreatment","sex","method","contributingLab","harvestDate"
"NLA_001","ApoE3 iAstrocytes drug screen metabolic panel","ApoE3/3, ApoE4/4","Astrocyte","BIONi037-A","NTC, NTC - ApoE4/4, 2-Deoxy-D-glucose, 24-hydroxy_cholesterol, Atglistatin, Atorvastatin, Avasimibe, Berberine, C75, Cholesterol, DMSO, Eliglustat, ETC1002, FSG67, FX11, GSK2837808A, GW4869, ND-630, Oleic acid, Opaganib, Palmitic acid, LXR623, Rapamycin, SBFI-26, SCDi, SH42, SR18292, T0070907, T0901317, Torcetapib, U-18666A","Female","SLA","van der Kant","2023/12/21"
"NLA_002","ApoE4 iAstrocytes drug screen metabolic panel","ApoE3/3, ApoE4/4","Astrocyte","BIONi037-A","NTC - ApoE3/3, NTC, 2-Deoxy-D-glucose, 24-hydroxy_cholesterol, ACM, Atglistatin, Atorvastatin, Avasimibe, Berberine, C75, Cholesterol, DMSO, Eliglustat, FSG67, FX11, GSK2837808A, GW4869, LXR623, ND-630, Oleic acid, Opaganib, Palmitic acid, Etomoxir, Rapamycin, Rotenone, SBFI-26, SCDi, SH42, SR18292, T0070907, T0901317, Torcetapib, U-18666A","Female","SLA","van der Kant","2023/12/21"
"NLA_003","ApoE4 vs ApoE3 isogenic iAstrocytes with FBS I (KolfJ2.1 Feringa and Koppes-den Hertog) ","ApoE3/3, ApoE4/4","Astrocyte","KOLF2.1J","","Male","SLA","van der Kant","2022/08/31"
"NLA_004","ApoE3 iAstrocytes FBS versus no FBS I (KolfJ2.1 Feringa and Koppes-den Hertog) ","ApoE3/3","Astrocyte","KOLF2.1J","","Male","SLA","van der Kant","2022/08/31"
"NLA_005","ApoE4 vs ApoE3 isogenic iAstrocytes no FBS I (KolfJ2.1 Feringa and Koppes-den Hertog) ","ApoE3/3, ApoE4/4","Astrocyte","KOLF2.1J","","Male","SLA","van der Kant","2022/08/31"
"NLA_007","ApoE4 vs ApoE3 isogenic iAstrocytes no FBS II (KolfJ2.1 Feringa and Koppes-den Hertog) ","ApoE4/4, ApoE3/3","Astrocyte","KOLF2.1J","","Male","SLA","van der Kant","2023/09/20"
"NLA_008","ApoE3 iAstrocytes FBS versus no FBS II (KolfJ2.1 Feringa and Koppes-den Hertog) ","ApoE3/3","Astrocyte","KOLF2.1J","","Male","SLA","van der Kant","2023/09/20"
"NLA_009","ApoE4 vs ApoE3 isogenic iAstrocytes with FBS II (KolfJ2.1 Feringa and Koppes-den Hertog) ","ApoE4/4, ApoE3/3","Astrocyte","KOLF2.1J","","Male","SLA","van der Kant","2023/09/20"
"NLA_010","Control vs reactive (IL1a_TNF_C1q) iAstrocytes (BIONI037-A Feringa and Koppes-den Hertog)","WT","Astrocyte","BIONi037-A","TNFa/Il1a/C1q, Vehicle","Female","SLA","van der Kant","13/10/2023"
"NLA_011","Control vs reactive (IL1a_TNF_C1q) iAstrocytes (KolfJ2.1 Feringa and Koppes-den Hertog)","WT","Astrocyte","KOLF2.1J","Vehicle, TNFa/Il1a/C1q","Male","SLA","van der Kant","13/10/2023"
"NLA_012","Control vs reactive (IL1a_TNF_C1q) iAstrocytes (WTC11 Rose)","WT","Astrocyte","WTC11","Vehicle, TNFa/Il1a/C1q","Male","SLA","Kampmann","2022/01/18"
"NLA_014","ApoE3 iAstrocytes FBS versus no FBS I (BIONi037-A Feringa and Koppes-den Hertog) ","ApoE3/3","Astrocyte","BIONi037-A","","Female","SLA","van der Kant","2021/12/22"
"NLA_015","ApoE4 vs ApoE3 isogenic iAstrocytes with FBS I (BIONi037-A Feringa and Koppes-den Hertog) ","ApoE3/3, ApoE4/4","Astrocyte","BIONi037-A","","Female","SLA","van der Kant","2021/12/22"
"NLA_017","ApoE4 vs ApoE3 isogenic iAstrocytes no FBS I (BIONi037-A Feringa and Koppes-den Hertog) ","ApoE3/3, ApoE4/4","Astrocyte","BIONi037-A","","Female","SLA","van der Kant","2021/12/22"
"NLA_018","alpha-synuclein E46K neurons (van der Kant lab)","SNCA E46K, SNCA WT","Neuron","KOLF2.1J","","Male","SLA","van der Kant","2021/12/13"
"NLA_020","ApoE4 vs ApoE3 isogenic iAstrocytes with FBS II (BIONi037-A Feringa and Koppes-den Hertog) ","ApoE3/3, ApoE4/4","Astrocyte","BIONi037-A","","Female","SLA","van der Kant","2022/04/21"
"NLA_021","ApoE3 iAstrocytes FBS versus no FBS II (BIONi037-A Feringa and Koppes-den Hertog) ","ApoE3/3","Astrocyte","BIONi037-A","","Female","SLA","van der Kant","2022/04/21"
"NLA_023","ApoE4 vs ApoE3 isogenic iAstrocytes no FBS II (BIONi037-A Feringa and Koppes-den Hertog) ","ApoE3/3, ApoE4/4","Astrocyte","BIONi037-A","","Female","SLA","van der Kant","2022/04/21"
"NLA_024","TMEM106B SS185 vs TT185 vs Null iNeurons (Ward lab)","TMEM106B SS185, TMEM106B KO, TMEM106B TT185","Neuron","KOLF2.1J","","Male","SLA","Michael Ward","2022/08/14, 2022/08/08, 2022/08/11"
"NLA_025","Mouse cortex ApoE4 vs ApoE3 target replacement mice 3 months old","ApoE3/3, ApoE4/4","Mouse","Cortex","","Female","SLA","van der Kant","2020/10/29"
"NLA_026","Mouse cortex ApoE4 vs ApoE3 target replacement mice 6 months old","ApoE3/3, ApoE4/4","Mouse","Cortex","","Female","SLA","van der Kant","2021/01/14"
"NLA_027","IPSC-derived neurons, microglia and astrocytes (Feringa and Koppes-den Hertog) ","ApoE3/3","Neuron, Astrocyte, Microglia","BIONi037-A, Bioni037-A","no_FBS","Female","SLA","van der Kant, Deborah Kronenberg","2021/07/21, 2021/12/22, 2022/07/22"
"NLA_028","Human cerebellum AD vs control (Feringa and Koppes-den Hertog) ","ApoE4/4, ApoE2/3, ApoE2/4, ApoE3/3, ApoE2/2, ApoE3/4","Human","Cerebellum","AD, Control","Male, Female","SLA","van der Kant","Unknown"
"NLA_029","Human prefrontal cortex gray matter AD vs control (Feringa and Koppes-den Hertog) ","ApoE3/3, ApoE4/4, ApoE2/3, ApoE3/4, ApoE2/2, ApoE2/4","Human","Frontal Cortex gray matter","AD, Control","Male, Female","SLA","van der Kant","Unknown"
"NLA_030","Human prefrontal cortex white matter AD vs control (Feringa and Koppes-den Hertog) ","ApoE3/3, ApoE2/3, ApoE3/4, ApoE4/4, ApoE2/4, ApoE2/2","Human","Frontal Cortex white matter","Control, AD","Male, Female","SLA","van der Kant","Unknown"
"NLA_031","Human prefrontal cortex gray matter, white matter and cerebellum all control (Feringa and Koppes-den Hertog)","ApoE2/3, ApoE3/3, ApoE2/4, ApoE3/4, ApoE2/2","Human","Cerebellum, Frontal Cortex white matter, Frontal Cortex gray matter","Control","Female, Male","SLA","van der Kant","Unknown"
"NLA_032","Human iPSC-derived neurons. C9 line 1 and isogenic Control line 1 (from Giblin et al.). First neuronal induction.","C9orf72 no repeat expansion, C9orf72 G4C2 repeat expansion","Neuron","BS6","","Female","SLA","Isaacs","2021/12/07"
"NLA_033","Human iPSC-derived neurons. C9 line 1 and isogenic Control line 1 (from Giblin et al.). Second neuronal induction.","C9orf72 no repeat expansion, C9orf72 G4C2 repeat expansion","Neuron","BS6","","Female","SLA","Isaacs","2022/05/18"
"NLA_034","Human iPSC-derived neurons.  Control line 1 transduced with C9 repeat lentiviruses (from Giblin et al.). First neuronal induction.","C9orf72 no repeat expansion","Neuron","BS6","LV-(G4C2)2, LV-(G4C2)92","Female","SLA","Isaacs","2022/06/10"
"NLA_035","Human iPSC-derived neurons. C9 line 1 and isogenic Control line 1 (from Giblin et al.). Third neuronal induction.","C9orf72 G4C2 repeat expansion, C9orf72 no repeat expansion","Neuron","BS6","","Female","SLA","Isaacs","2023/06/27"
"NLA_036","Human iPSC-derived neurons. C9 line 1 treated with C9-knockdown antisense oligonucleotides (from Giblin et al.). First neuronal induction.","C9orf72 G4C2 repeat expansion","Neuron","BS6","Non-targeting ASO, C9-targeting ASO","Female","SLA","Isaacs","2023/06/23"
"NLA_037","Human iPSC-derived neurons. C9 line 2 treated with C9-knockdown antisense oligonucleotides (from Giblin et al.). First neuronal induction.","C9orf72 G4C2 repeat expansion","Neuron","KOLF2.1J","Non-targeting ASO, C9-targeting ASO","Male","SLA","Isaacs","2023/06/23, 2023/06/26"
"NLA_038","Human iPSC-derived neurons.  Control line 2 transduced with C9 repeat lentiviruses (from Giblin et al.). First neuronal induction.","C9orf72 no repeat expansion","Neuron","WTc11","LV-(G4C2)2, LV-(G4C2)92","Male","SLA","Isaacs","2022/09/30"
"NLA_039","Human iPSC-derived neurons.  Control line 1 transduced with C9 repeat lentiviruses (from Giblin et al.). Second neuronal induction.","C9orf72 no repeat expansion","Neuron","BS6","LV-(G4C2)2, LV-(G4C2)92","Female","SLA","Isaacs","2022/11/08"
"NLA_040","Human iPSC-derived neurons. C9 line 1 treated with C9-knockdown antisense oligonucleotides (from Giblin et al.). Second neuronal induction.","C9orf72 G4C2 repeat expansion","Neuron","BS6","Non-targeting ASO, C9-targeting ASO","Female","SLA","Isaacs","2022/10/17"
"NLA_041","Human iPSC-derived neurons. C9 line 1 treated with C9-knockdown antisense oligonucleotides (from Giblin et al.). Third neuronal induction.","C9orf72 G4C2 repeat expansion","Neuron","BS6","Non-targeting ASO, C9-targeting ASO","Female","SLA","Isaacs","2022/11/08"
"NLA_042","Human iPSC-derived neurons. C9 line 2 and isogenic Control line 3 (from Giblin et al.). First neuronal induction.","C9orf72 G4C2 repeat expansion, C9orf72 no repeat expansion","Neuron","KOLF2.1J","","Male","SLA","Isaacs","2023/03/08"
"NLA_043","Human iPSC-derived neurons. C9 line 2 and isogenic Control line 3 (from Giblin et al.). Second neuronal induction.","C9orf72 G4C2 repeat expansion, C9orf72 no repeat expansion","Neuron","KOLF2.1J","","Male","SLA","Isaacs","2023/03/14"
"NLA_044","Human iPSC-derived neurons. C9 line 2 and isogenic Control line 3 (from Giblin et al.). Third neuronal induction.","C9orf72 G4C2 repeat expansion, C9orf72 no repeat expansion","Neuron","KOLF2.1J","","Male","SLA","Isaacs","2023/03/30"
"NLA_045","Human iPSC-derived neurons. C9 line 3 treated with C9-knockdown antisense oligonucleotides (from Giblin et al.). First neuronal induction.","C9orf72 G4C2 repeat expansion","Neuron","KOLF2.1J","Non-targeting ASO, C9-targeting ASO","Male","SLA","Isaacs","2023/03/08"
"NLA_046","Human iPSC-derived neurons. C9 line 3 treated with C9-knockdown antisense oligonucleotides (from Giblin et al.). Second neuronal induction.","C9orf72 G4C2 repeat expansion","Neuron","KOLF2.1J","C9-targeting ASO, Non-targeting ASO","Male","SLA","Isaacs","2023/03/30"
"NLA_047","Human iPSC-derived neurons. C9 line 1 and isogenic Control line 1 (from Giblin et al.). Combined replicates from all neuronal inductions.","C9orf72 no repeat expansion, C9orf72 G4C2 repeat expansion","Neuron","BS6","","Female","SLA","Isaacs","2021/12/07, 2022/05/18, 2023/06/27"
"NLA_048","Human iPSC-derived neurons.  Control lines 1 and 2 transduced with C9 repeat lentiviruses (from Giblin et al.). Combined replicates from all neuronal inductions.","C9orf72 no repeat expansion","Neuron","BS6, WTc11","LV-(G4C2)2, LV-(G4C2)92","Female, Male","SLA","Isaacs","2022/06/10, 2022/09/30, 2022/11/08"
"NLA_049","Human iPSC-derived neurons. C9 line 1 treated with C9-knockdown antisense oligonucleotides (from Giblin et al.). Combined replicates from all neuronal inductions.","C9orf72 G4C2 repeat expansion","Neuron","BS6","Non-targeting ASO, C9-targeting ASO","Female","SLA","Isaacs","2022/10/17, 2022/11/08, 2023/06/23"
"NLA_050","Human iPSC-derived neurons. C9 line 3 treated with C9-knockdown antisense oligonucleotides (from Giblin et al.). Combined replicates from all neuronal inductions.","C9orf72 G4C2 repeat expansion","Neuron","KOLF2.1J","Non-targeting ASO, C9-targeting ASO","Male","SLA","Isaacs","2023/03/08, 2023/03/30"
"NLA_051","Human iPSC-derived neurons. C9 line 3 and isogenic Control line 3 (from Giblin et al.). Combined replicates from all neuronal inductions.","C9orf72 G4C2 repeat expansion, C9orf72 no repeat expansion","Neuron","KOLF2.1J","","Male","SLA","Isaacs","2023/03/14, 2023/03/08, 2023/03/30"
"NLA_052","Human iPSC-derived neurons. C9 line 2 and isogenic Control line 3 (from Giblin et al.). Combined replicates from all neuronal inductions.","C9orf72 G4C2 repeat expansion, C9orf72 no repeat expansion","Neuron","KOLF2.1J","","Male","SLA","Isaacs","2023/03/30, 2023/03/08, 2023/03/14"
"NLA_053","Human iPSC-derived neurons. C9 line 3 and isogenic Control line 3 (from Giblin et al.). First neuronal induction.","C9orf72 G4C2 repeat expansion, C9orf72 no repeat expansion","Neuron","KOLF2.1J","","Male","SLA","Isaacs","2023/03/08"
"NLA_054","Human iPSC-derived neurons. C9 line 3 and isogenic Control line 3 (from Giblin et al.). Second neuronal induction.","C9orf72 G4C2 repeat expansion, C9orf72 no repeat expansion","Neuron","KOLF2.1J","","Male","SLA","Isaacs","2023/03/14"
"NLA_055","Human iPSC-derived neurons. C9 line 3 and isogenic Control line 3 (from Giblin et al.). Third neuronal induction.","C9orf72 no repeat expansion, C9orf72 G4C2 repeat expansion","Neuron","KOLF2.1J","","Male","SLA","Isaacs","2023/03/30"
